scabies
SCABIES
Scabies is a contagious disease caused by the mite Sarcoptes scabiei var hominis.
The affected individual usually complains of having a highly pruritic rash that occurs at night.
It occurs more often in children <15 years of age, sexually active young adults, the immunocompromised and in persons living in crowded living conditions (eg nursing homes, military barracks).
Transmission is typically by direct skin contact with an infected person and in adults, sexual transmission is common.

Introduction

  • Diagnosis is made based on clinical presentation & can be confirmed by microscopic identification of mites, eggs or mite feces
  • Scabies should be suspected in a patient who presents w/ a highly pruritic rash w/ nocturnal predominance
    • Scabies is highly suggested if there is also a history of contact w/ an infected person or if there is a history of contact w/ family member or sexual partner who has pruritic lesions w/ nocturnal predominance
  • Scabies is caused by the mite: Sarcoptes scabiei var hominis

Signs and Symptoms

Clinical Presentation

  • Occurs more often in children <15 yr, sexually active young adults, the immunocompromised & in persons living in crowded living conditions (eg nursing homes, military barracks)
  • Transmission is typically by direct skin contact w/ an infected person & in adults, sexual transmission is common
    • Though there is limited documentation, transmission by fomites may be possible (esp in cases of crusted scabies where a large amt of parasites are involved)
    • The mites can live for up to 30 days on a host & remain alive for 3 days on furniture, bedding etc
Signs & Symptoms
  • Primary symptom is generalized pruritus, which is usually worse at night
    • Pruritus is caused by a hypersensitivity reaction to the mite & its products (saliva, eggs & feces) once the host becomes sensitized
    • Hypersensitivity occurs 4-6 wk after infestation but occurs in 1-4 days w/ re-infestation because the host has been previously sensitized
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Dr. Joseph Delano Fule Robles, 12 Feb 2019

A team of investigators from the University of Hong Kong (HKU) identified high-risk Epstein Barr virus (EBV) variants present in 97 percent of nasopharyngeal carcinoma (NPC) cases.

5 days ago
New drug applications approved by US FDA as of 01- 15 February 2019 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Pearl Toh, 23 Aug 2018
Restoration of CD4/CD8 ratio on combination antiretroviral therapy (cART) was associated with decreased risk of Kaposi sarcoma (KS) while baseline CD8 count was related to non-Hogkin lymphoma (NHL) risk in people living with HIV (PLHIV) who had achieved viral suppression on cART, according to the COHERE* study presented at the AIDS International Conference (AIC) 2018.
Roshini Claire Anthony, 16 Jan 2019

A once-daily oral dose of sofosbuvir and velpatasvir for 12 weeks leads to sustained virological response (SVR) in a majority of patients with chronic hepatitis C virus (HCV) infection, according to an Asian study. However, the efficacy of this regimen may be reduced in patients with HCV genotype 3b with cirrhosis.